About

Why EnzymeBase exists

EnzymeBase grew out of an ongoing research program on Alzheimer’s disease mechanisms, based at the Department of Medical Laboratory Technology, Syedza Saintika University, West Sumatra, Indonesia. One strand of that program looks at natural compounds from Indonesian flora, beginning with the genus Uncaria, as candidate inhibitors of disease-relevant enzymes such as BACE1 and AChE.

Findings like these often stay inside a single thesis or manuscript. EnzymeBase keeps them usable past that point: an open, citable record that other researchers working on the same enzyme targets or the same source species can build on directly.

Scope, for now

EnzymeBase currently covers two enzyme targets tied to neurodegenerative disease, BACE1 and AChE, and natural inhibitor candidates from Indonesian biodiversity. See Platform for how an entry moves from an initial screen to a validated, citable record, and Entries for what is catalogued so far.

Who is behind it

EnzymeBase is maintained by Bramadi Arya, a lecturer in the Department of Medical Laboratory Technology at Syedza Saintika University. Read more about the wider research program at bramadiarya.com.

For questions or collaboration, see Get Involved.